Clearwater Paper Corporation — FY2013 Form 10-K
Business context and reporting period. The filing covers the fiscal year ended December 31, 2013; it is an annual report, not a standalone fourth-quarter filing. Clearwater Paper produces private-label tissue and premium bleached paperboard through Consumer Products and Pulp and Paperboard segments.
Financial results and liquidity
- Revenue: $1.890 billion, up 0.8% from $1.874 billion in 2012. Consumer Products sales were $1.150 billion; Pulp and Paperboard sales were $740.1 million.
- Profitability: Operating income was $99.3 million, down from $145.4 million; operating margin declined to 5.3% from 7.8%. Net earnings rose to $107.0 million from $64.1 million, and diluted EPS to $4.80 from $2.72. The increase in net income largely reflects a $68.7 million tax benefit, not stronger operating income.
- Segment performance: Consumer Products operating income fell to $52.8 million from $93.3 million (margin 4.6% versus 8.2%). Pulp and Paperboard operating income declined to $95.8 million from $103.9 million (margin 12.9% versus 14.0%).
- Fourth quarter: Revenue was $470.2 million versus $462.7 million in Q4 2012; operating income was $38.3 million versus $35.5 million. Net earnings were $82.9 million versus $19.9 million, principally reflecting the fourth-quarter tax benefit from releasing uncertain tax reserves.
- Cash flow and investment: Operating cash flow was $136.4 million, down from $198.7 million. Cash used in investing was $140.6 million, including $90.6 million of plant and equipment additions. Year-end cash was $23.7 million and short-term investments were $70.0 million.
- Debt and liquidity: Long-term debt was $650.0 million, up from $523.9 million; debt to total capitalization was 49.5%, versus 44.4%. No revolver borrowings were outstanding; approximately $118.4 million was available, net of letters of credit. The latest fixed-charge coverage ratio was 2.5x.
- Other metrics: Working capital was $376.0 million versus $293.7 million. Adjusted EBITDA, a non-GAAP measure, was $199.7 million versus $229.1 million.
Material changes versus 2012
- Sales increased modestly, helped by higher retail tissue prices and shipments and increased paperboard shipments. Paperboard pricing was nearly flat.
- Operating performance weakened as cost of sales rose to 88.4% of revenue from 85.8%. Drivers included $15.7 million of TAD transition costs, $10.7 million of additional depreciation on the North Carolina TAD machine, $6.0 million of Thomaston closure costs, and higher energy, packaging and other costs.
- Cash from operations declined in part because working capital used $15.0 million, compared with generating $61.3 million in 2012; inventory increased to support the TAD program.
- The company issued $275 million of 4.5% notes due 2023 and redeemed $150 million of 10.625% notes due 2016, recording $17.1 million of debt-retirement costs. It also repurchased $100 million of shares during 2013.
Outlook, risks and unusual items
- Management said operating cash, cash on hand, short-term investments and revolver capacity should fund debt service, operations, capital expenditures and working capital for the next 12 months. The filing gives no earnings or revenue guidance; the estimated 2014 effective tax rate is approximately 38%.
- The North Carolina TAD expansion was ramping up, with management seeking to optimize production, product mix and customer acceptance. Competitor capacity growth and pricing pressure could limit expected benefits.
- After year-end, the company announced the immediate closure of its Long Island converting and distribution facility, estimating $12–$15 million in exit costs, mostly in 2014.
- Key exposures include customer concentration (three customers represented about 20% of total sales), volatile pulp, wood fiber, energy and transportation costs, manufacturing disruptions, and labor negotiations. Four collective bargaining agreements were due to expire in 2014.
- The EPA and DOJ were continuing discussions over alleged Clean Air Act violations at the Lewiston, Idaho facility; the tolling agreement ran through July 31, 2014 unless extended. The filing does not quantify a probable loss.
- Company-sponsored pension plans were underfunded by $6.8 million at year-end, and estimated 2014 qualified-plan contributions were about $15 million. A potential complete withdrawal from the underfunded PIUMPF multiemployer plan was estimated to entail more than $72 million in aggregate pretax liability, subject to uncertainty.
- Environmental compliance projects under a new air-emissions rule were estimated at $5–$7 million, primarily during 2015–2017. Management reported no material environmental liability was currently known.
Important facts for investors to verify
- How much of reported 2013 net income and Q4 EPS came from the tax-reserve release and biofuel tax credits, and whether those benefits recur.
- Whether TAD utilization, customer acceptance and pricing can improve Consumer Products margins after transition costs and ramp-up expenses.
- Whether operating cash flow recovers as inventory normalizes, given lower 2013 cash generation and planned capital and pension spending.
- The final costs and savings from the Thomaston and Long Island closures, and the outcome and potential cost of the Lewiston environmental matter.
- Debt-service capacity and covenant headroom under weaker operating conditions, alongside planned share repurchases and pension obligations.